Pfizer's Groton lab researching safety of COVID-19 vaccine

Pfizer is developing, and researching its vaccine in Connecticut.

News 12 Staff

Nov 10, 2020, 5:15 PM

Updated 1,311 days ago


Pfizer is developing and researching its vaccine in Connecticut.
Pfizer is already producing enough COVID-19 vaccines for up to 20 million people.
The drug maker says its 90% effective in preventing the virus. Pfizer's lab in Groton will research how safe the vaccine is.
Dr. Zane Saul, an immunologist at Bridgeport Hospital, says the numbers are impressive, but there is still a lot we don't know.
"The way they defined it was, 90% of the people were COVID-free after two shot[s] of the vaccine -- three weeks apart -- as compared to placebo. So those are huge numbers and great news," says Saul.
A Data Haven survey found that 20% of Connecticut residents don't plan to get a COVID-19 vaccine, and 17% said they're "not sure."
If the vaccine does get federal approval, state officials say medical workers will be the first to receive it.
Connecticut already has a draft plan to distribute a vaccine.

More from News 12